4 completed, 3 unknown, 1 terminated. 8 Phase 1, 4 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 8 | Completed 4, Unknown 3, Terminated 1 |
| Phase 2 | 4 | Completed 3, Unknown 1 |
Follow Liver Diseases, Alcoholic: new trials by email Literature Review of Liver Diseases, Alcoholic trials Research Report on Liver Diseases, Alcoholic
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety Evaluation of Fecal Microbiota Transplantation in Severe Alcoholic Hepatitis Fecal Microbiota Transplantation, Placebo - Alcoholic Hepatitis | Phase 1 / Phase 2 | Unknown | Prasun Kumar Jalal | 50 | 2023-01-21 | 2025-01-23 |
| Study of Decompensated Alcoholic Cirrhosis Treatment by Stem Cells Conventional therapy plus low dose UCMSCs treatment, Conventional therapy plus medium dose UCMSCs treatment, Conventional therapy plus high dose UCMSCs treatment - Alcoholic Cirrhosis | Phase 1 | Unknown | Yantai Yuhuangding Hospital | 36 | 2022-06-13 | 2023-03-28 |
| Guselkumab (Anti-IL 23 Monoclonal Antibody) for Alcohol Associated Liver Disease Guselkumab 30mg, Guselkumab 70mg, Guselkumab 100mg - Alcoholic Liver Disease | Phase 1 | Completed | University of California, San Diego | 13 | 2021-03-03 | 2024-08-06 |
| Study to Evaluate Hepatic Artery Injection of Autologous Human Bone Marrow-Derived MSCs in Patients With Alcoholic LC Cellgram™ (Bone marrow-derived MSCs) - Alcoholic Liver Cirrhosis | Phase 1 | Unknown | Pharmicell Co., Ltd. | 10 | 2019-06-20 | 2020-10-22 |
| Use of F-652 in Patients With Alcoholic Hepatitis F-652 - Alcoholic Hepatitis | Phase 1 / Phase 2 | Completed | Mayo Clinic | 18 | 2016-02-01 | 2019-09-09 |
| Effect of Candesartan in Alcoholic Liver Fibrosis candesartan for hepatic fibrosis - Alcoholic Liver Disease | Phase 1 / Phase 2 | Completed | Yonsei University | 85 | 2005-09-01 | 2009-10-07 |
| Pentoxifylline for Acute Alcoholic Hepatitis (AAH) pentoxifylline - Hepatitis, Alcoholic | Phase 1 | Terminated | University of Wisconsin, Madison | 4 | 2005-03-01 | 2014-05-13 |
| Efficacy of Baclofen in the Treatment of Alcohol Addiction Baclofen, placebo - Liver Cirrhosis, Alcoholic | Phase 1 / Phase 2 | Completed | Catholic University of the Sacred Heart | 86 | 2003-02-01 | 2007-09-05 |
Hepatitis, Alcoholic (3) · Liver Cirrhosis, Alcoholic (3) · Liver Cirrhosis (2) · Alcoholism (1) · Fibrosis (1) · Liver Diseases (1)
Alcohol-Induced Disorders (8) · Alcohol-Related Disorders (8) · Chemically-Induced Disorders (8) · Digestive System Diseases (8) · Substance-Related Disorders (8) · Liver Diseases (7) · Pathologic Processes (4) · Pathological Conditions, Signs and Symptoms (4) · Fibrosis (3) · Hepatitis (3) · Liver Cirrhosis (2) · Mental Disorders (1)
Baclofen (1) · Fecal Microbiota Transplantation (1) · Pentoxifylline (1) · candesartan (1) · candesartan cilexetil (1) · eflepedocokin alfa (1) · guselkumab (1)
Catholic University of the Sacred Heart (1) · Mayo Clinic (1) · Pharmicell Co., Ltd. (1) · Prasun Kumar Jalal (1) · University of California, San Diego (1) · University of Wisconsin, Madison (1) · Yantai Yuhuangding Hospital (1) · Yonsei University (1)
United States (4) · China (1) · South Korea (1)
Giovanni Addolorato, M.D. (1) · Juan Gallegos-Orozco, Ph.D (1) · Jun Cui, MD (1) · Michael R Lucey, MD (1) · Rohit Loomba (1) · Soon Koo Baik, Professor (1) · Vijay Shah, MD (1)